Ozempic and similar drugs may reduce risk of 42 health conditions but carry potential side effects

Recent research indicates that GLP-1 drugs, like Ozempic, may lower the risk of 42 health conditions, including dementia and addiction disorders. This marks a significant expansion in understanding their potential benefits beyond weight loss. However, the study also identified risks associated with these medications, such as gastrointestinal issues and kidney problems. These findings highlight the need for careful monitoring of patients using GLP-1 drugs. Despite their effectiveness, many patients discontinue GLP-1 drugs due to high costs and side effects, which can lead to rapid weight gain. Ongoing research aims to clarify the long-term effects and risks of these medications.